Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 2351 to 2375 of about 5880

Previous 25

Website Changes

01/19/2013

IBTA E NEWS JANUARY 2013

01/19/2013

The Cancer Support Community is conducting a new survey to help develop educational materials and programs

01/19/2013

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

01/18/2013

Dedifferentiation—Turning Back the Cellular Clock

01/14/2013

Delayed response and survival from NovoTTF-100A in recurrent GBM

01/14/2013

Added new article about a case report on a long term survivor from the Novocure trial

01/11/2013

Brains Matter Webinar Series. "Top 10 Vital Questions to Ask When Diagnosed with a Brain Tumor"

01/10/2013

Musella Foundation Co-Pay Assist Program closed.

01/09/2013

"National Cancer Comprehensive Network" adds "alternating electric field therapy" (Novocure) to it`s treatment guidelines for treatment of recurrent glioblastoma

01/06/2013

Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.

12/30/2012

The Methodist Hospital and Remeditex LLC Work to Develop Brain Tumor Drug

12/30/2012

Musella Foundation For Brain Tumor Research & Information, Inc 2012 Highlights

12/27/2012

Survival odds increase for brain tumor

12/27/2012

Electric field treatment takes aim at brain cancer

12/20/2012

Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin/Ran protein complex.

12/20/2012

Surgical extent impacts the value of the established prognosticators in glioblastoma patients: a prospective translational study in Asia.

12/20/2012

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.

12/20/2012

Brain tumors in raccoons linked to newly discovered virus

12/19/2012

Voices Against Brain Cancer Hosts Contest on Facebook to Recognize Brain Cancer Scientists and Social Workers

12/16/2012

Musella Foundation Grant Award to Tocagen - Interim Progress Report

12/11/2012

IBTA E News December 2012

12/05/2012

Peregrine Shows Desperation in Dusting Off Ancient Brain Tumor Drug

12/04/2012

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study.

12/03/2012

Advancing “Breakthrough” Drug Therapies

11/30/2012

Correction: video name is: Bringing Light Please vote!

Our privacy / cookie policy has changed.
Click HERE to read it!